Search results
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 18 hours agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab | CNN
CNN.com· 11 hours agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse ...
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Motley Fool via Yahoo Finance· 4 hours agoJohnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth...
Advisory Panel of Experts Endorses FDA Approval of New Alzheimer’s Drug
The New York Times via Yahoo News· 3 hours agoAlzheimer’s afflicts more than 6 million Americans. It has no cure, and there is no treatment or...
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 1 day agoEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a...
Stocks making the biggest moves premarket: Eli Lilly, General Motors, Shopify
CNBC· 2 hours agoThese are the stocks posting the largest moves in premarket trading.
FDA panel backs Eli Lilly’s Alzheimer’s drug
The Hill· 16 hours agoA federal advisory panel on Monday voted in favor of recommending Eli Lilly’s new drug that is under consideration for its potential to slow the...
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Yahoo Finance via AOL· 20 hours agoEli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound —...
US medical advisers vote to recommend Eli Lilly Alzheimer drug
Medical Xpress· 6 hours agoAn independent panel of US medical experts voted Monday to recommend Eli Lilly's experimental Alzheimer's drug, meaning there could soon be another treatment ...
Shell Asset Management Co. Sells 12,465 Shares of Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 1 day agoShell Asset Management Co. lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 21.7% in the fourth quarter, Holdings Channel.com ...